Stanley-Laman Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Stanley-Laman Group's IDXX Position: Q2 2022 in Review
Stanley-Laman Group sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 754 shares — an estimated $412K sold.
Stanley-Laman Group first reported a position in IDXX in Q2 2015 and held it in 17 quarters. The position peaked at $15.8M in Q3 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.
- Stanley-Laman Group reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
- Stanley-Laman Group sold 754 Idexx Laboratories shares in Q2 2022, an estimated $412K.
- Stanley-Laman Group first reported a position in Idexx Laboratories in Q2 2015 and held it in 17 quarters.
- Stanley-Laman Group's Idexx Laboratories position peaked at $15.8M in Q3 2021.
- 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.
Based on Stanley-Laman Group's 13F filing for Q2 2022, filed 8 Aug 2022.